Evotaz Tablet
Pricing Report NDC 0003-3641-11

Current NADAC: $52.04790 per EA · Effective Sep 23, 2026 · Est. package price $1,561.44 (30 EA)

Current Package Pricing Information

The current wholesale acquisition cost for Evotaz (NDC 0003-3641-11) is $52.04790 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Sep 23, 2026.

As a a human prescription drug provided by E.r. Squibb & Sons, L.l.c., this medication is distributed in a 30 TABLET in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$52.04790
Per EA

Effective Date
Sep 23, 2026
Billable Units
30 EA
Estimated Package Price
$1,561.44
Data Status
As of Oct 07, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
30 TABLET in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jun 2015, the NADAC wholesale price for (NDC ) has moved within a range of $44.90160 to $52.10412 per EA. Over this 11 years and 3 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$44.9016 - $52.1041
Market Volatility
16.04% Variance
Latest Trend
0.06%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Sep 23, 2026 $52.04790 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Aug 19, 2026 $52.01618 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jul 22, 2026 $51.96427 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jun 17, 2026 $51.98204 EAC/I - Chain or Independent PharmacyCode 1B - Brand
May 20, 2026 $51.98626 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Apr 22, 2026 $51.95037 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Mar 18, 2026 $51.97854 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Feb 18, 2026 $51.96748 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jan 21, 2026 $51.93939 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Dec 17, 2025 $52.00813 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Nov 19, 2025 $51.97165 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Oct 22, 2025 $51.98429 EAC/I - Chain or Independent PharmacyCode 1B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026